Dermatological complications and safety of anti-TNF treatments

被引：71
|
作者：
Kerbleski, Joseph F. [1 ]
Gottlieb, Alice B. [1 ]
机构：
[1] Tufts Med Ctr, Dept Dermatol, Boston, MA 02111 USA
来源：
GUT | 2009年 / 58卷 / 08期
关键词：
TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; INFUSION REACTIONS; FACTOR-ALPHA; COMBINATION THERAPY; CROHNS-DISEASE; RISK-FACTORS; INFLIXIMAB; INFECTIONS; MANAGEMENT;
D O I：
10.1136/gut.2008.163683
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
It has been reported that tumour necrosis factor (TNF) inhibitors have adverse side-effects including infections, malignancies, demyelinating disease, and induction of autoimmune conditions. Dermatological complications of anti-TNF therapy include injection site reactions, cutaneous infections, allergic rashes, psoriasis, non-melanoma skin cancer (NMSC), and rare reports of lupus-like syndrome, erythema multiforme (EM), Steven's Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN).
引用
收藏
页码：1033 / 1039
页数：7
相关论文
共 50 条
  • [21] Local experience of switching anti-TNFα treatments for rheumatoid arthritis
    Smale, S. W.
    Amos, N.
    Morgans, G. L.
    Lewis, K. E.
    Camilleri, J. P.
    RHEUMATOLOGY, 2007, 46 : I31 - I31
  • [22] Anti-TNF therapy: Safety aspects of taking the risk
    Rosenblum, Hemda
    Amital, Howard
    AUTOIMMUNITY REVIEWS, 2011, 10 (09) : 563 - 568
  • [23] Dermatological Complications of Anti-TNF-α Therapy in Crohn's Disease
    Nardelli, Andrea
    Chauhan, Usha K.
    Marshall, John K.
    Halder, Smita L.
    Tse, Frances
    Lima, Hermenio
    Pinto-Sanchez, Maria I.
    Moayyedi, Paul
    Bercik, Premysl
    Armstrong, David
    GASTROENTEROLOGY, 2014, 146 (05) : S583 - S583
  • [24] DEVELOPMENT OF NEUROLOGICAL COMPLICATIONS AFTER THERAPY WITH ANTI-TNF DRUGS
    Errazquin, N.
    Meneses, C.
    Uriarte, M.
    Egues, C. A.
    Belzunegui, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 466 - 466
  • [25] Benefit of Earlier Anti-TNF Treatment on IBD Disease Complications?
    Nuij, Veerle
    Fuhler, Gwenny M.
    Edel, Annemarie J.
    Ouwendijk, Rob J. T.
    Rijk, Marno C. M.
    Beukers, Ruud
    Quispel, Rutger
    van Tilburg, Antonie J. P.
    Tang, Thjon J.
    Smalbraak, Hermen
    Bruin, Karlien F.
    Lindenburg, Flordeliz
    Peyrin-Biroulet, Laurent
    van der Woude, C. Janneke
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (11): : 997 - 1003
  • [26] Immediate complications of 3,555 injections of anti-TNFα
    Bertacini de Moraes, Julio Cesar
    Aikawa, Nadia Emi
    de Medeiros Ribeiro, Ana Cristina
    Schain Saad, Carla Goncalves
    de Carvalho, Jozelio Freire
    Rodrigues Pereira, Rosa Maria
    Almeida Silva, Clovis Artur
    Bonfa, Eloisa
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2010, 50 (02) : 165 - 175
  • [27] COMBINATION OF ACTIVE AND PASSIVE ANTI-TNFα TREATMENTS IN HUMAN-TNFα TRANSGENIC MICE
    Semerano, Luca
    Biton, Jerome
    Delavallee, Laure
    Duvallet, Emilie
    Bernier, Emilie
    Grouard-Vogel, Geraldine
    Boissier, Marie-Christophe
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 : A70 - A70
  • [28] Dermatological conditions during anti-TNF treatment in patients with rheumatoid arthritis: A prospective study
    Flendrie, M
    Vissers, WHPM
    Creemers, MCW
    De Jong, EMGJ
    Van de Kerkhof, PCM
    Van Riel, PLCM
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 433 - 433
  • [29] Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments
    Kollias, G
    Kontoyiannis, D
    CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (4-5) : 315 - 321
  • [30] GENERAL PRACTITIONER PERCEPTIONS OF METHOTREXATE AND ANTI-TNF TREATMENTS: A QUALITATIVE STUDY
    Berthet, E.
    De Rosa, M.
    Lopez, J.
    Vorilhon, P.
    Soubrier, M.
    Mathieu, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1268 - 1268
12345